Medicare Enrolled
Dr. David Enis, M.D., PH.D.
Dermatology · Huntingdon Valley, PA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Enis from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Enis?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Enis
Dr. David Enis is a dermatology specialist in Huntingdon Valley, PA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Enis performed 8,068 Medicare services across 4,271 unique beneficiaries.
Between the years covered by Open Payments, Dr. Enis received a total of $7,595 from 40 pharmaceutical and/or device companies across 476 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in dermatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Enis is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 7% volume in PA
$7,595 industry payments
Medicare Practice Summary
Medicare Utilization ↗8,068
Medicare services
Top 7% in PA for dermatology
4,271
Unique beneficiaries
$52
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~425 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
2,513 | $6 | $48 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,104 | $95 | $180 |
| Skin biopsy, tangential A procedure to remove a sample of the first identified skin growth for laboratory examination. |
957 | $76 | $150 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
920 | $67 | $135 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
879 | $39 | $100 |
| Additional skin growth biopsy Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session. |
694 | $43 | $93 |
| Destruction of cancer skin growth, 1.1-2.0 cm Removal of a cancerous skin growth on the trunk, arms, or legs that measures between 1.1 and 2.0 centimeters. |
149 | $128 | $267 |
| Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | 107 | $142 | $288 |
| Destruction of skin growths (warts/lesions), 1-14 This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface. |
101 | $84 | $250 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
95 | $77 | $224 |
| Ear tissue biopsy A procedure to remove a small sample of tissue from the ear for laboratory examination. |
91 | $51 | $199 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
72 | $123 | $242 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
53 | $1 | $16 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
42 | $39 | $95 |
| Shaving of skin growth, 0.6-1.0 cm A minor procedure to shave off a skin growth on the body, arms, or legs that measures between 0.6 and 1.0 centimeters. |
37 | $90 | $231 |
| Intermediate wound repair, 2.6-7.5 cm A medical procedure to close a wound on the scalp, underarms, trunk, arms, or legs that measures between 2.6 and 7.5 centimeters. This type of repair involves cleaning the wound and stitching it closed to promote healing. |
37 | $256 | $435 |
| Destruction of 15 or more precancerous skin growths This procedure involves the removal or destruction of fifteen or more precancerous skin lesions. It is performed to treat abnormal skin cells that have the potential to develop into cancer. |
37 | $139 | $316 |
| Injection into skin growths, 1-7 A procedure involving the injection of medication into one to seven skin growths. |
31 | $33 | $95 |
| Removal of noncancer skin growth, 1.1-2.0 cm This procedure involves the surgical removal of a benign skin growth located on the body, arms, or legs. The growth measured between 1.1 and 2.0 centimeters in diameter. |
27 | $74 | $250 |
| Skin growth shaving, 0.5 cm or less This procedure involves shaving off a small skin growth measuring 0.5 centimeters or less from the body, arms, or legs. |
26 | $60 | $208 |
| Acne surgery A surgical procedure to treat acne. The specific techniques and extent of the surgery are not defined in this general code description. |
22 | $91 | $235 |
| Punch biopsy of first skin growth A small, circular piece of skin is removed from a skin growth using a circular blade. The sample is then sent to a laboratory for examination. |
21 | $103 | $190 |
| Skin tag removal, 1-15 tags This procedure involves the removal of one to fifteen skin tags. It is a minor surgical intervention to excise these benign growths from the skin. |
16 | $47 | $250 |
| Shaving of small skin growth on face or mouth area A minor procedure to shave off a small skin growth, measuring 0.5 cm or less, located on the face, ears, eyelids, nose, lips, or mouth. |
15 | $78 | $175 |
| Shaving of skin growth, 0.6-1.0 cm A minor procedure to shave off a skin growth measuring 0.6 to 1.0 cm from the scalp, neck, hands, feet, or genitals. |
11 | $107 | $185 |
| Intermediate wound repair, 7.6-12.5 cm This procedure involves stitching a wound on the scalp, underarms, trunk, arms, or legs that measures between 7.6 and 12.5 centimeters. It includes cleaning the wound and closing it with sutures to promote healing. |
11 | $290 | $470 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.3% high complexity
22.9% medium
76.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$7,595
Total received (2018-2024)
Avg $1,085/year across 7 years
Top 21% in PA for dermatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
40
Companies
476
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,482 (98.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$113 (1.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,700
2023
$1,305
2022
$892
2021
$356
2020
$778
2019
$1,180
2018
$1,384
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Arcutis Biotherapeutics, Inc.
$254
Janssen Biotech, Inc.
$240
Amgen Inc.
$185
E.R. Squibb & Sons, L.L.C.
$172
Novartis Pharmaceuticals Corporation
$155
Lilly USA, LLC
$115
LEO Pharma Inc.
$108
SUN PHARMACEUTICAL INDUSTRIES INC.
$107
PFIZER INC.
$97
ABBVIE INC.
$70
Incyte Corporation
$58
Dermavant Sciences, Inc.
$52
Regeneron Healthcare Solutions, Inc.
$31
GENZYME CORPORATION
$30
UCB, Inc.
$25
Top 3 companies account for 40.0% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Biotech, Inc.
$1,114
LEO Pharma Inc.
$875
Novartis Pharmaceuticals Corporation
$679
Arcutis Biotherapeutics, Inc.
$478
ABBVIE INC.
$438
VYNE Pharmaceuticals Inc.
$394
Regeneron Healthcare Solutions, Inc.
$323
E.R. Squibb & Sons, L.L.C.
$284
PFIZER INC.
$278
Amgen Inc.
$265
Sun Pharmaceutical Industries Inc.
$248
AbbVie, Inc.
$246
AbbVie Inc.
$243
Incyte Corporation
$230
GENZYME CORPORATION
$219
Lilly USA, LLC
$197
Galderma Laboratories, L.P.
$171
SUN PHARMACEUTICAL INDUSTRIES INC.
$134
Celgene Corporation
$113
PruGen, Inc. Pharmaceuticals
$82
Dermavant Sciences, Inc.
$75
Mayne Pharma Inc.
$61
UCB, Inc.
$60
Boehringer Ingelheim Pharmaceuticals, Inc.
$60
Sandoz Inc.
$34
Ortho Dermatologics, a division of Bausch Health US, LLC
$31
Taro Pharmaceuticals USA, Inc.
$31
EPI Health, LLC
$30
Bayer HealthCare Pharmaceuticals Inc.
$28
Almirall LLC
$22
DUSA Pharmaceuticals, Inc.
$20
Mylan Pharmaceuticals Inc.
$18
Biofrontera Inc.
$17
Novum Pharma, LLC
$16
Promius Pharma LLC
$15
Genentech USA, Inc.
$15
MAYNE PHARMA INC.
$14
Merck Sharp & Dohme Corporation
$13
Mission Pharmacal Company
$13
Journey Medical Corporation
$11
Top 3 companies account for 35.1% of all-time payments
Associated products mentioned in payments ›
0.25% · ABSORICA (isotretinoin) · ABSORICA LD · ADBRY · AKLIEF · AMZEEQ · Absorica LD · Alcortin A · Ameluz · Avar · Bensal HP · Bimzelx · CIBINQO · COSENTYX · Cimzia · DORYX · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · ELIDEL · ENSTILAR · EPIDUO FORTE · EUCRISA · Erivedge · Exelderm · Finacea · HALOG (Halcinonide Cream · HUMIRA · Humira · ILUMYA · ILUMYA (tildrakizumab-asmn) injection · Ilumya · KERYDIN · LEVULAN KERASTICK · LIBTAYO · OLUMIANT · ONEXTON · OPZELURA · ORACEA · Olux · Otezla · Promiseb Complete · REMICADE · RINVOQ · SIVEXTRO · SKYRIZI · SOOLANTRA · SPEVIGO · Sotyktu · TALTZ · TOPICORT (desoximetasone) Topical Spray · TREMFYA · TWYNEO · Tremfya · USP) 0.1% · VTAMA · Veltin · WYNZORA · Winlevi · ZILXI · Zoryve
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Dermatologists within 10 mi
336
Per 100K population
39.0
County median income
$111,521
Nearest hospital
HOLY REDEEMER HOSPITAL AND MEDICAL CENTER
3.1 mi
3.1 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Enis is a clinical cardiology specialist, with above-average Medicare volume (top 7% in PA), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Enis experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Enis performed 2,513 destruction of precancerous skin growths, 2-14 services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Enis receive payments from pharmaceutical companies?
Yes. Dr. Enis received a total of $7,595 from 40 companies across 476 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Enis's costs compare to other dermatologists in Huntingdon Valley?
Dr. Enis's average Medicare payment per service is $52. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Enis) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Dermatologists in Huntingdon Valley
Browse dermatologists in Huntingdon Valley ranked by procedure volume and transparency data.
Highest volume
Top Dermatologists in PA
Dermatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Dermatologists in PA
Which PA dermatologists receive the most from drug and device companies.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
LEO Pharma Inc. Payments to Doctors
See all physicians who received payments from LEO Pharma Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology